StockMacro
Menu

DaVita

$161.03 -18% in 6 monthsMarket cap $10.1B

DVA on XNYS, Health Care, DaVita Inc., job postings

Measures activity, not value. Not investment advice.

Twelve-month profit rose 19% to $920.1M, but insiders sold $69M in the last 90 days.

  • BadFederal contracts and grants: $235M over 12 months, down from $482.9M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Industry
Services-misc health & allied services, nec (Health Care)
Employees
78,000
Website
davita.com
Listed
NYSE, US
Last results
29 Oct 2026
Next results
expected around 1 Feb 2027 (an estimate: a year ago it reported on 2 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $3.6B, net income $222.9M.
Quarter to 31 Dec 2021: revenue $2.9B, net income $187.5MQuarter to 31 Dec 2021: revenue $2.9B, net income $187.5MQuarter to 31 Mar 2022: revenue $2.8B, net income $162.1MQuarter to 31 Mar 2022: revenue $2.8B, net income $162.1MQuarter to 30 Jun 2022: revenue $2.9B, net income $224.8MQuarter to 30 Jun 2022: revenue $2.9B, net income $224.8MQuarter to 30 Sep 2022: revenue $2.9B, net income $105.4MQuarter to 30 Sep 2022: revenue $2.9B, net income $105.4MQuarter to 31 Dec 2022: revenue $2.9B, net income $68.1MQuarter to 31 Dec 2022: revenue $2.9B, net income $68.1MQuarter to 31 Mar 2023: revenue $2.9B, net income $115.5MQuarter to 31 Mar 2023: revenue $2.9B, net income $115.5MQuarter to 30 Jun 2023: revenue $3.0B, net income $178.7MQuarter to 30 Jun 2023: revenue $3.0B, net income $178.7MQuarter to 30 Sep 2023: revenue $3.1B, net income $246.6MQuarter to 30 Sep 2023: revenue $3.1B, net income $246.6MQuarter to 31 Dec 2023: revenue $3.1B, net income $150.7MQuarter to 31 Dec 2023: revenue $3.1B, net income $150.7MQuarter to 31 Mar 2024: revenue $3.1B, net income $239.6MQuarter to 31 Mar 2024: revenue $3.1B, net income $239.6MQuarter to 30 Jun 2024: revenue $3.2B, net income $222.7MQuarter to 30 Jun 2024: revenue $3.2B, net income $222.7MQuarter to 30 Sep 2024: revenue $3.3B, net income $214.7MQuarter to 30 Sep 2024: revenue $3.3B, net income $214.7MQuarter to 31 Dec 2024: revenue $3.3B, net income $259.3MQuarter to 31 Dec 2024: revenue $3.3B, net income $259.3MQuarter to 31 Mar 2025: revenue $3.2B, net income $162.9MQuarter to 31 Mar 2025: revenue $3.2B, net income $162.9MQuarter to 30 Jun 2025: revenue $3.4B, net income $199.3MQuarter to 30 Jun 2025: revenue $3.4B, net income $199.3MQuarter to 30 Sep 2025: revenue $3.4B, net income $150.3MQuarter to 30 Sep 2025: revenue $3.4B, net income $150.3MQuarter to 31 Dec 2025: revenue $3.6B, net income $234.2MQuarter to 31 Dec 2025: revenue $3.6B, net income $234.2MQuarter to 31 Mar 2026: revenue $3.4B, net income $197.5MQuarter to 31 Mar 2026: revenue $3.4B, net income $197.5MQuarter to 30 Jun 2026: revenue $3.6B, net income $265.4MQuarter to 30 Jun 2026: revenue $3.6B, net income $265.4MQuarter to 30 Sep 2026: revenue $3.6B, net income $222.9MQuarter to 30 Sep 2026: revenue $3.6B, net income $222.9M
31 Dec 2021RevenueNet incometallest bar $3.6B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$3.6B$222.9M
30 Jun 2026$3.6B$265.4M
31 Mar 2026$3.4B$197.5M
31 Dec 2025$3.6B$234.2M
30 Sep 2025$3.4B$150.3M
30 Jun 2025$3.4B$199.3M
31 Mar 2025$3.2B$162.9M
31 Dec 2024$3.3B$259.3M
30 Sep 2024$3.3B$214.7M
30 Jun 2024$3.2B$222.7M
31 Mar 2024$3.1B$239.6M
31 Dec 2023$3.1B$150.7M
30 Sep 2023$3.1B$246.6M
30 Jun 2023$3.0B$178.7M
31 Mar 2023$2.9B$115.5M
31 Dec 2022$2.9B$68.1M
30 Sep 2022$2.9B$105.4M
30 Jun 2022$2.9B$224.8M
31 Mar 2022$2.8B$162.1M
31 Dec 2021$2.9B$187.5M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $14.2B $13.3B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +6.4% +3.8%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $920.1M $771.9M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $13.51 $9.69
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 56.0%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 15.0% 15.4% 7.8%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 6.5% 5.8% 5.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. – -9.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $1.3B $1.3B
CashCash, cash equivalents and short-term investments on the latest balance sheet. $566.3M $736.5M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $10.8B $10.2B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $10.2B $9.5B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.06
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 11.0 24.7
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.71 1.1
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.4 1.2
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. – 4.1

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
DaVitaDVA (this company) $10.1B11.00.71+6.4%6.5%
Sotera HealthSHC $4.5B26.23.7+6.9%14.1%
ProgynyPGNY $2.6B28.92.0+5.5%6.8%
agilon healthAGL $1.5Bloss0.25+2.0%-1.5%
EnsignENSG $10.3B25.81.8+17%7.0%
Universal Health ServicesUHS $10.3B7.10.56+8.0%8.0%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$69.0M

bought $0, sold $69.0M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+0.7%

618 13F filers vs 614

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

96%

60.2M shares held by 13F filers (30 Sep 2026) of 62.9M outstanding (27 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

8.2%

5.1M shares sold short (30 Oct 2026) of 62.9M outstanding (27 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.1

5.1M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+4.8%

4.9M shares sold short in the report before, 5.1M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

66%

66% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 65%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

3,381

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

-4.3%

67 vs 70 applications

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+4.6%

$3.6B vs $3.4B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-4.0%

$159.5M vs $166.1M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$235.0M

the 12 months before: $482.9M

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$4.5M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

31

31 articles in the last 7 days; its usual week has 4.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

6.9×

31 articles in the last 7 days; its usual week has 4.5.

Price $161.03 on 20 Nov 2026, +40% over 12 months (12-month range $103.87 to $240.96)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $523.4M in the last 12 months (the 12 months before: -$628.8M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 67 published in the last 12 months, -4.3% on the 12 months before.
Revenue per quarter. Revenue $3.6B in the latest quarter, +4.6% on a year earlier.
Capital spending per quarter. Capital spending $159.5M in the latest quarter, -4.0% on a year earlier.
Institutional holders (13F filers). 618 13F filers reported holding it in the latest 13F quarter, +18% on a year earlier.
Federal obligations. Federal obligations: $127.6M published in the last 12 months, -78% on the 12 months before.
Lobbying spend. Lobbying spend: $4.5M published in the last 12 months, -16% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
19 May 2026Sharp changeMany funds opening a new position: many funds opening a new position, 106 vs usual 60.50 (2026-03-31); 1.5x the same period a year earlier
6 Jan 2026Sharp changeFederal obligations jump: federal obligations jump, 121.4M vs usual 0 in the same month of earlier years (2025-12-01..2025-12-31); 0.9x the same month a year earlier
9 Dec 2025Sharp changeFederal obligations jump: federal obligations jump, 27.2M vs usual 704K in the same month of earlier years (2025-11-01..2025-11-30); 85.1x the same month a year earlier
6 Nov 2025Sharp changeFederal obligations jump: federal obligations jump, 26.9M vs usual 621K in the same month of earlier years (2025-10-01..2025-10-31); 27.7x the same month a year earlier
9 Sep 2025Sharp changeFederal obligations jump: federal obligations jump, 26.2M vs usual 0 in the same month of earlier years (2025-08-01..2025-08-31)
7 Aug 2025Sharp changeFederal obligations jump: federal obligations jump, 33.7M vs usual 2,074.50 in the same month of earlier years (2025-07-01..2025-07-31)
8 Jul 2025Sharp changeFederal obligations jump: federal obligations jump, 303.6M vs usual 43K in the same month of earlier years (2025-06-01..2025-06-30)
7 May 2025Lobbying filingnew lobbying registration (CONTINENTAL STRATEGY, LLC)
21 Apr 2025Lobbying filinglobbying engagement terminated (AVOQ, LLC)
8 Apr 2025Sharp changeFederal obligations jump: federal obligations jump, 12.1M vs usual 933K in the same month of earlier years (2025-03-01..2025-03-31); 20.5x the same month a year earlier
7 Apr 2025Lobbying filinglobbying engagement terminated (HORIZON GOVERNMENT AFFAIRS)
7 Feb 2025Lobbying filingnew lobbying registration (S-3 GROUP)
21 Jan 2025Lobbying filinglobbying engagement terminated (WEST FRONT STRATEGIES LLC)
9 Jan 2025Lobbying filingnew lobbying registration (APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL))
7 Jan 2025Sharp changeFederal obligations jump: federal obligations jump, 131.1M vs usual -47K in the same month of earlier years (2024-12-01..2024-12-31); -642.4x the same month a year earlier
13 Sep 20248-K and other filingsDirector or officer change
13 Sep 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
10 Apr 20248-K and other filingsDirector or officer change
10 Apr 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 Feb 2024Sharp changeShort interest spike: short interest spike, 5.0M vs usual 3.0M (2024-01-31); 1.8x the same period a year earlier
30 Jan 2024Sharp changeShort interest spike: short interest spike, 5.9M vs usual 3.0M (2024-01-12); 2.1x the same period a year earlier
19 Jan 2024Lobbying filinglobbying engagement terminated (AKIN GUMP STRAUSS HAUER & FELD)
16 Jan 2024Sharp changeShort interest spike: short interest spike, 5.4M vs usual 2.9M (2023-12-29); 2.1x the same period a year earlier
2 Jan 2024Sharp changeShort interest spike: short interest spike, 6.0M vs usual 2.9M (2023-12-15); 2.2x the same period a year earlier
12 Dec 2023Sharp changeShort interest spike: short interest spike, 6.4M vs usual 2.9M (2023-11-30); 2.1x the same period a year earlier
28 Nov 2023Sharp changeShort interest spike: short interest spike, 6.7M vs usual 2.9M (2023-11-15); 2.2x the same period a year earlier
14 Nov 2023Sharp changeShort interest spike: short interest spike, 5.1M vs usual 2.9M (2023-10-31); 1.4x the same period a year earlier
31 Oct 2023Sharp changeShort interest spike: short interest spike, 5.7M vs usual 2.9M (2023-10-13); 1.5x the same period a year earlier
13 Oct 2023Lobbying filingnew lobbying registration (HORIZON GOVERNMENT AFFAIRS)
27 Jul 2023Lobbying filingnew lobbying registration (WEST FRONT STRATEGIES LLC)
25 Jul 20238-K and other filingsDirector or officer change
21 Jul 2023Sharp changeLobbying on a new issue: lobbying on a new issue: LBR (2023-06-30)
13 Jul 20238-K and other filingsDirector or officer change
13 Jul 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
23 May 2023Lobbying filingnew lobbying registration (TOM BRADLEY HEALTH POLICY LLC)
21 Mar 20238-K and other filingsDirector or officer change
21 Mar 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
23 Jan 2023Lobbying filinglobbying engagement terminated (JEFFERSON BUSINESS CONSULTING, LLC)
7 Jan 2023Lobbying filingnew lobbying registration (PARK GOVERNMENT RELATIONS, LLC)
3 Jan 2023Lobbying filinglobbying engagement terminated (PARK GOVERNMENT RELATIONS, LLC)
18 Oct 2022Lobbying filingnew lobbying registration (POWERS PYLES SUTTER & VERVILLE, P.C.)
13 Sep 2022Sharp changeShort interest spike: short interest spike, 5.6M vs usual 3.2M (2022-08-31); 2.2x the same period a year earlier
13 Sep 20228-K and other filingsDirector or officer change
13 Sep 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Aug 2022Sharp changeShort interest spike: short interest spike, 5.5M vs usual 3.2M (2022-08-15); 2.2x the same period a year earlier
19 Jul 2022Sharp changeShort interest spike: short interest spike, 5.2M vs usual 2.9M (2022-06-30); 2.2x the same period a year earlier
7 Apr 20228-K and other filingsDirector or officer change
7 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
26 Jan 2022Lobbying filingnew lobbying registration (PARK GOVERNMENT RELATIONS, LLC)
Insider net buying (open market)
Month from 1 Nov 2021: -$46K published
Month from 1 Feb 2022: -$80K published
Month from 1 Jun 2022: $1.3M published
Month from 1 Nov 2022: $356K published
Month from 1 Mar 2023: -$168K published
Month from 1 May 2023: -$4.3M published
Month from 1 Aug 2023: -$997K published
Month from 1 Feb 2024: -$17.5M published
Month from 1 May 2024: -$698K published
Month from 1 Aug 2024: -$24.4M published
Month from 1 Sep 2024: -$9.9M published
Month from 1 Feb 2025: -$147.7M published
Month from 1 May 2025: -$196.3M published
Month from 1 Jul 2025: -$353K published
Month from 1 Aug 2025: -$230.0M published
Month from 1 Oct 2025: -$54.3M published
Month from 1 Feb 2026: -$199.9M published
Month from 1 May 2026: -$200.1M published
Month from 1 Jun 2026: -$17.7M published
Month from 1 Aug 2026: -$36.5M published
Month from 1 Oct 2026: -$69.0M published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 18 published
Quarter from 1 Apr 2022: 22 published
Quarter from 1 Jul 2022: 18 published
Quarter from 1 Oct 2022: 11 published
Quarter from 1 Jan 2023: 8 published
Quarter from 1 Apr 2023: 19 published
Quarter from 1 Jul 2023: 20 published
Quarter from 1 Oct 2023: 15 published
Quarter from 1 Jan 2024: 9 published
Quarter from 1 Apr 2024: 15 published
Quarter from 1 Jul 2024: 13 published
Quarter from 1 Oct 2024: 13 published
Quarter from 1 Jan 2025: 13 published
Quarter from 1 Apr 2025: 24 published
Quarter from 1 Jul 2025: 17 published
Quarter from 1 Oct 2025: 16 published
Quarter from 1 Jan 2026: 11 published
Quarter from 1 Apr 2026: 15 published
Quarter from 1 Jul 2026: 19 published
Quarter from 1 Oct 2026: 22 published
Revenue per quarter
Quarter ended 31 Dec 2021: $2.9B, +1.3% on a year earlier; public on 12 Feb 2022
Quarter ended 31 Mar 2022: $2.8B, -0.1% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $2.9B, +0.4% on a year earlier; public on 2 Aug 2022
Quarter ended 30 Sep 2022: $2.9B, +0.4% on a year earlier; public on 1 Nov 2022
Quarter ended 31 Dec 2022: $2.9B, -0.9% on a year earlier; public on 23 Feb 2023
Quarter ended 31 Mar 2023: $2.9B, +2.0% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $3.0B, +2.5% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $3.1B, +5.9% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $3.1B, +7.8% on a year earlier; public on 15 Feb 2024
Quarter ended 31 Mar 2024: $3.1B, +6.9% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $3.2B, +6.2% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $3.3B, +4.6% on a year earlier; public on 30 Oct 2024
Quarter ended 31 Dec 2024: $3.3B, +4.7% on a year earlier; public on 14 Feb 2025
Quarter ended 31 Mar 2025: $3.2B, +5.0% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $3.4B, +6.1% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $3.4B, +4.8% on a year earlier; public on 30 Oct 2025
Quarter ended 31 Dec 2025: $3.6B, +9.9% on a year earlier; public on 12 Feb 2026
Quarter ended 31 Mar 2026: $3.4B, +6.0% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $3.6B, +5.2% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $3.6B, +4.6% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $189.6M, -16% on a year earlier; public on 12 Feb 2022
Quarter ended 31 Mar 2022: $123.1M, -15% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $142.4M, -4.8% on a year earlier; public on 2 Aug 2022
Quarter ended 30 Sep 2022: $143.9M, -8.6% on a year earlier; public on 1 Nov 2022
Quarter ended 31 Dec 2022: $194.0M, +2.4% on a year earlier; public on 23 Feb 2023
Quarter ended 31 Mar 2023: $147.7M, +20% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $124.5M, -13% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $136.8M, -4.9% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $159.0M, -18% on a year earlier; public on 15 Feb 2024
Quarter ended 31 Mar 2024: $121.0M, -18% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $124.7M, +0.2% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $139.0M, +1.6% on a year earlier; public on 30 Oct 2024
Quarter ended 31 Dec 2024: $170.7M, +7.3% on a year earlier; public on 14 Feb 2025
Quarter ended 31 Mar 2025: $143.3M, +18% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $121.1M, -2.9% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $166.1M, +19% on a year earlier; public on 30 Oct 2025
Quarter ended 31 Dec 2025: $145.4M, -15% on a year earlier; public on 12 Feb 2026
Quarter ended 31 Mar 2026: $102.0M, -29% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $169.8M, +40% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $159.5M, -4.0% on a year earlier; public on 30 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 434; public on 14 Feb 2022
31 Mar 2022 report: 478; public on 16 May 2022
30 Jun 2022 report: 436; public on 15 Aug 2022
30 Sep 2022 report: 397; public on 14 Nov 2022
31 Dec 2022 report: 401; public on 14 Feb 2023
31 Mar 2023 report: 404; public on 15 May 2023
30 Jun 2023 report: 423; public on 14 Aug 2023
30 Sep 2023 report: 456; public on 14 Nov 2023
31 Dec 2023 report: 491; public on 14 Feb 2024
31 Mar 2024 report: 509; public on 15 May 2024
30 Jun 2024 report: 530; public on 14 Aug 2024
30 Sep 2024 report: 564; public on 14 Nov 2024
31 Dec 2024 report: 572; public on 14 Feb 2025
31 Mar 2025 report: 567; public on 15 May 2025
30 Jun 2025 report: 565; public on 14 Aug 2025
30 Sep 2025 report: 525; public on 14 Nov 2025
31 Dec 2025 report: 513; public on 17 Feb 2026
31 Mar 2026 report: 569; public on 15 May 2026
30 Jun 2026 report: 614; public on 14 Aug 2026
30 Sep 2026 report: 618; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $0 published
Month from 1 Dec 2021: $725K published
Month from 1 Jan 2022: -$57K published
Month from 1 Mar 2022: $0 published
Month from 1 Apr 2022: $1.4M published
Month from 1 May 2022: $157K published
Month from 1 Jun 2022: -$27K published
Month from 1 Aug 2022: -$138K published
Month from 1 Sep 2022: -$61K published
Month from 1 Oct 2022: $281.4M published
Month from 1 Nov 2022: $572K published
Month from 1 Dec 2022: $339K published
Month from 1 Jan 2023: -$66K published
Month from 1 Feb 2023: -$84K published
Month from 1 Mar 2023: $933K published
Month from 1 Apr 2023: $0 published
Month from 1 May 2023: $135K published
Month from 1 Jun 2023: $43K published
Month from 1 Aug 2023: $143K published
Month from 1 Oct 2023: $250.6M published
Month from 1 Nov 2023: $915K published
Month from 1 Dec 2023: -$415K published
Month from 1 Jan 2024: -$54.6 published
Month from 1 Feb 2024: -$42K published
Month from 1 Mar 2024: -$133K published
Month from 1 Apr 2024: $550K published
Month from 1 May 2024: -$339K published
Month from 1 Jul 2024: $236K published
Month from 1 Oct 2024: $532K published
Month from 1 Nov 2024: $319K published
Month from 1 Dec 2024: $131.1M published
Month from 1 Jan 2025: $447K published
Month from 1 Feb 2025: $1.1M published
Month from 1 Mar 2025: $935K published
Month from 1 Apr 2025: $11.2M published
Month from 1 May 2025: $0 published
Month from 1 Jun 2025: $303.6M published
Month from 1 Aug 2025: $59.9M published
Month from 1 Sep 2025: $26.7M published
Month from 1 Oct 2025: $26.9M published
Month from 1 Nov 2025: $27.2M published
Month from 1 Dec 2025: $121.4M published
Month from 1 Feb 2026: $1.8M published
Month from 1 Mar 2026: $431K published
Month from 1 Apr 2026: $205K published
Month from 1 May 2026: $3.7M published
Month from 1 Jun 2026: $248K published
Month from 1 Jul 2026: $260K published
Month from 1 Aug 2026: -$14K published
Month from 1 Sep 2026: -$1.0M published
Month from 1 Oct 2026: $259K published
Month from 1 Nov 2026: $292K published
Lobbying spend
Quarter from 1 Jan 2022: $920K published
Quarter from 1 Apr 2022: $1.3M published
Quarter from 1 Jul 2022: $870K published
Quarter from 1 Oct 2022: $970K published
Quarter from 1 Jan 2023: $980K published
Quarter from 1 Apr 2023: $1.0M published
Quarter from 1 Jul 2023: $970K published
Quarter from 1 Oct 2023: $1.0M published
Quarter from 1 Jan 2024: $1.0M published
Quarter from 1 Apr 2024: $1.1M published
Quarter from 1 Jul 2024: $1.0M published
Quarter from 1 Jan 2025: $2.1M published
Quarter from 1 Apr 2025: $1.1M published
Quarter from 1 Jul 2025: $1.1M published
Quarter from 1 Oct 2025: $1.0M published
Quarter from 1 Jan 2026: $1.1M published
Quarter from 1 Apr 2026: $1.2M published
Quarter from 1 Jul 2026: $980K published
Quarter from 1 Oct 2026: $1.1M published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is H-1B/E-3 applications certified at 10 (Aug 2026), 2.0× its normal month; higher than 93% of its own history.
  • Insider net buying (open market): Insiders sold a net $523.4M in the last 12 months (the 12 months before: -$628.8M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 67 published in the last 12 months, -4.3% on the 12 months before.
  • Revenue per quarter: Revenue $3.6B in the latest quarter, +4.6% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 1 sale, $69.0M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
29 Oct 2026Berkshire Hathaway Inc and 1 other10% ownerSell382,563$180.43$69.0MForm 4
4 Aug 2026Berkshire Hathaway Inc and 1 other10% ownerSell182,980$199.55$36.5MForm 4
17 Jun 2026Javier RodriguezChief Executive OfficerSell69,407$209.38$14.5MForm 4
17 Jun 2026Kathleen Alyce WatersChief Legal & Pub. Affairs OffSell15,405$208.40$3.2MForm 4
18 May 2026James O HeartyChief Compliance OfficerSellafter exercising options15,000$193.98$2.9MForm 4
13 May 2026David Paul MaughanChief Operating Officer, DKCSell20,529$199.22$4.1MForm 4
11 May 2026Joel AckermanCFO and TreasurerSell51,471$192.10$9.9MForm 4
8 May 2026James O HeartyChief Compliance OfficerSell2,184$174.87$382KForm 4

618 institutions reported shares at the end of Q3 2026, 96% of the shares outstanding; 80 opened a position, 82 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Berkshire Hathaway Inc28.7M45.6%$5.0B-183K-0.6%
BlackRock, Inc.2.7M4.35%$478.2M+273K+11%
Vanguard Capital Management LLC2.3M3.59%$395.2M+158K+7.5%
Morgan Stanley1.6M2.61%$287.2M+40K+2.5%
Vanguard Portfolio Management LLC1.6M2.50%$275.3M+196K+14%
Invesco Ltd.1.4M2.27%$249.4M+214K+18%
State Street Corp1.4M2.19%$241.0M+55K+4.1%
Geode Capital Management, LLC1.3M2.00%$219.3M+402K+47%
Dimensional Fund Advisors LP1.2M1.90%$209.2M+58K+5.1%
Arrowstreet Capital, Limited Partnership1.2M1.86%$204.5M+280K+31%

Federal contracts

All 37 federal contracts

2 new awards in 12 months, $125.2M obligated when signed. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
13 May 2026Department of Veterans Affairs$3.8MNATIONAL (VA-WIDE) DIALYSIS SERVICES EO 14398USAspending
17 Dec 2025Department of Veterans Affairs$121.4MEXPRESS REPORT: FY 26 NOVEMBER NDSC EXPRESS REPORTUSAspending
13 Nov 2025Department of Veterans Affairs$26.9MEXPRESS REPORT: FY 26 OCTOBER NDSC EXPRESS REPORTUSAspending
16 Oct 2025Department of Veterans Affairs$26.8MEXPRESS REPORT: FY 25 SEPTEMBER NDSC EXPRESS REPORTUSAspending
17 Sep 2025Department of Veterans Affairs$26.8MEXPRESS REPORT: FY 25 AUGUST NDSC EXPRESS REPORTUSAspending
20 Aug 2025Department of Veterans Affairs$26.3MEXPRESS REPORT: FY 25 JULY NDSC EXPRESS REPORTUSAspending
28 Jul 2025Department of Veterans Affairs$11.3MEXPRESS REPORT: FY 25 JUNE NDSC EXPRESS REPORTUSAspending
28 Jul 2025Department of Veterans Affairs$22.4MEXPRESS REPORT: FY 25 MAY NDSC EXPRESS REPORTUSAspending

Company events

All 48 company events

In 12 months: 2 major agreements. Results releases and routine reports are left out.

FiledWhat happenedSource
8 Jun 2026Signed a major agreementSame filing: took on new debt, shareholder vote results8-K
25 Nov 2025Signed a major agreementSame filing: took on new debt8-K
17 Jul 2025Signed a major agreementSame filing: took on new debt8-K
23 May 2025Signed a major agreementSame filing: took on new debt8-K
13 Sep 2024Director or officer change8-K
14 Aug 2024Signed a major agreementSame filing: took on new debt8-K
13 May 2024Signed a major agreementSame filing: took on new debt8-K
1 May 2024Signed a major agreement8-K

3,381 open postings; careers site tracked since 21 Nov 2026. Most in Operations & administration 6%, Executive & administrative support 2%, Facilities & construction 1%, Sales & business development 1%.

PostedJobLocation
21 Nov 2026Registered Nurse111 Yopp Rd, Jacksonville, NC 28540-3509
21 Nov 2026Clinical CoordinatorOperations & administration4770 Shallotte Ave., Shallotte, NC 28470
21 Nov 2026Patient Care Technician3497 South Dixie Hwy, Franklin, OH 45005
21 Nov 2026Patient Care Technician (FLOAT)213 Letton Dr, Paris, KY 40361-2251
21 Nov 2026Patient Care Technician4421 Roosevelt Blvd Ste D, Middletown, OH 45044
21 Nov 2026Registered Nurse (FLOAT)1745 Alysheba Way, Lexington, KY 40509
21 Nov 2026Patient Care Technician4435 Aicholtz Rd, Ste 800a, Cincinnati, OH 45245-1692
21 Nov 2026Patient Care Technician7502 State Road, Suite 1160, Cincinnati, OH 452552800

Reported lobbying spend: $1.1M in Q3 2026, $980K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
28 Apr 2025NewContinental Strategy, LLCfor Davita, Inc.Medicare and Medicaid reimbursement policies for specific kidney treatments.Health issuesFiling
31 Mar 2025EndedHorizon Government Affairsfor Davita, Inc.Not statedFiling
31 Jan 2025EndedAvoq, LLCfor Davita IncIssues related to Medicare payment for End Stage Renal Disease (ESRD); Issues related to health care workforce shortageHealth issues, LaborFiling
1 Jan 2025NewS-3 Groupfor Davita, Inc.Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Persepective Payment System (PPS)Health issuesFiling
31 Dec 2024EndedWest Front Strategies LLCfor Davita Inc.Issues related to the Medicare Secondary Payer Act, including HR 6860 and S. 5018, Restore Protections for Dialysis Patients Act; Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act, H.R. 5074/S. 4510; issues related to home dialysis.; Issues related to the National Dialysis Services Contracts.Medicare/Medicaid, VETFiling
1 Sep 2024NewApollo Government Relations (D/B/A Apollo Counsel)for Davita, IncAccess to healthcare servicesHealth issues, Medicare/MedicaidFiling
31 Dec 2023EndedAkin Gump Strauss Hauer & Feldfor Davita, Inc.Not statedFiling
1 Sep 2023NewHorizon Government Affairsfor Davita, Inc.Medicare provider reimbursement issuesHealth issuesFiling

The 5 newest of 356 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

8 Oct 2019confirmed

Confirmed across sources Government contracts and Short interest and volume

DaVita (DVA): had 22.5M shares sold short in the 30 Aug 2019 report, 3.5× the same report last year, while it booked $150.8M in federal contract and grant obligations in September 2019, 2,554× the same month last year. Two unrelated kinds of activity within 28 days.

  • Short interest and volume: Short interest spike, became public on 12 Sep 2019
  • Short interest and volume: Short interest spike, became public on 25 Sep 2019
  • Government contracts: Federal obligations jump, became public on 6 Oct 2019
  • Short interest and volume: Short interest spike, became public on 10 Oct 2019
2018-08-31: 6.4M2018-09-14: 6.2M2018-09-28: 5.3M2018-10-15: 5.8M2018-10-31: 5.0M2018-11-15: 4.3M2018-11-30: 5.0M2018-12-14: 4.0M2018-12-31: 3.9M2019-01-15: 4.1M2019-01-31: 5.0M2019-02-15: 4.1M2019-02-28: 4.4M2019-03-15: 4.5M2019-03-29: 4.5M2019-04-15: 5.0M2019-04-30: 5.3M2019-05-15: 5.4M2019-05-31: 6.1M2019-06-14: 6.7M2019-06-28: 8.2M2019-07-15: 9.6M2019-07-31: 9.1M2019-08-15: 14.7M2019-08-30: 22.5M
The 30 Aug 2019 report against the 24 reports before it. this reportearliernormal: 5.2M
See the evidence (4 changes)

Short interest and volume: Short interest spike became public on 12 Sep 2019

DaVita had 22.5M shares sold short in the 30 Aug 2019 report, 3.5× the same report last year.

This period
22.5M (the 30 Aug 2019 report)
Normal report (median of 24 earlier)
5.2M
Typical spread (median absolute deviation)
921K
How far from its usual level
+12.7
Same report last year
6.4M
History used
609 days
2018-08-31: 6.4M2018-09-14: 6.2M2018-09-28: 5.3M2018-10-15: 5.8M2018-10-31: 5.0M2018-11-15: 4.3M2018-11-30: 5.0M2018-12-14: 4.0M2018-12-31: 3.9M2019-01-15: 4.1M2019-01-31: 5.0M2019-02-15: 4.1M2019-02-28: 4.4M2019-03-15: 4.5M2019-03-29: 4.5M2019-04-15: 5.0M2019-04-30: 5.3M2019-05-15: 5.4M2019-05-31: 6.1M2019-06-14: 6.7M2019-06-28: 8.2M2019-07-15: 9.6M2019-07-31: 9.1M2019-08-15: 14.7M2019-08-30: 22.5M
the 30 Aug 2019 report24 earlier reportsnormal: 5.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Sep 2019

DaVita had 13.1M shares sold short in the 13 Sep 2019 report, 2.1× the same report last year.

This period
13.1M (the 13 Sep 2019 report)
Normal report (median of 24 earlier)
5.2M
Typical spread (median absolute deviation)
921K
How far from its usual level
+5.8
Same report last year
6.2M
History used
623 days
2018-09-14: 6.2M2018-09-28: 5.3M2018-10-15: 5.8M2018-10-31: 5.0M2018-11-15: 4.3M2018-11-30: 5.0M2018-12-14: 4.0M2018-12-31: 3.9M2019-01-15: 4.1M2019-01-31: 5.0M2019-02-15: 4.1M2019-02-28: 4.4M2019-03-15: 4.5M2019-03-29: 4.5M2019-04-15: 5.0M2019-04-30: 5.3M2019-05-15: 5.4M2019-05-31: 6.1M2019-06-14: 6.7M2019-06-28: 8.2M2019-07-15: 9.6M2019-07-31: 9.1M2019-08-15: 14.7M2019-08-30: 22.5M2019-09-13: 13.1M
the 13 Sep 2019 report24 earlier reportsnormal: 5.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Government contracts: Federal obligations jump became public on 6 Oct 2019

DaVita booked $150.8M in federal contract and grant obligations in September 2019, 2,554× the same month last year.

This period
$150.8M (September 2019)
Normal month (median of 5 earlier)
$59K
Typical spread (median absolute deviation)
$62K
How far from its usual level
+150.7
Same month last year
$59K
History used
4,337 days
2014-09-01: $02015-09-01: $02016-09-01: $41.3M2017-09-01: $126.8M2018-09-01: $59K2019-09-01: $150.8M
September 20195 earlier monthsnormal: $59K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

Check it at the source: USAspending.gov award search.

Short interest and volume: Short interest spike became public on 10 Oct 2019

DaVita had 10.9M shares sold short in the 30 Sep 2019 report, 2.1× the same report last year.

This period
10.9M (the 30 Sep 2019 report)
Normal report (median of 24 earlier)
5.2M
Typical spread (median absolute deviation)
921K
How far from its usual level
+4.2
Same report last year
5.3M
History used
640 days
2018-09-28: 5.3M2018-10-15: 5.8M2018-10-31: 5.0M2018-11-15: 4.3M2018-11-30: 5.0M2018-12-14: 4.0M2018-12-31: 3.9M2019-01-15: 4.1M2019-01-31: 5.0M2019-02-15: 4.1M2019-02-28: 4.4M2019-03-15: 4.5M2019-03-29: 4.5M2019-04-15: 5.0M2019-04-30: 5.3M2019-05-15: 5.4M2019-05-31: 6.1M2019-06-14: 6.7M2019-06-28: 8.2M2019-07-15: 9.6M2019-07-31: 9.1M2019-08-15: 14.7M2019-08-30: 22.5M2019-09-13: 13.1M2019-09-30: 10.9M
the 30 Sep 2019 report24 earlier reportsnormal: 5.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 19 May 2026Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G26N0046 ($3.8M) (dated 13 May 2026)

  2. 15 May 2026Institutional holdings change

    saw 106 13F filers open a new position in the quarter ended 31 Mar 2026, 1.5× the same quarter last year.

    Same quarter last year: 73; its normal quarter is 60.5.

    See the evidence
    This period
    106 (the quarter ended 31 Mar 2026)
    Normal quarter (median of 8 earlier)
    60.5
    Typical spread (median absolute deviation)
    8
    How far from its usual level
    +3.8
    Same quarter last year
    73
    History used
    4,565 days
    2024-03-31: 612024-06-30: 692024-09-30: 792024-12-31: 472025-03-31: 732025-06-30: 602025-09-30: 572025-12-31: 532026-03-31: 106
    the quarter ended 31 Mar 20268 earlier quartersnormal: 60.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  3. 23 Dec 2025Government contracts change

    booked $121.4M in federal contract and grant obligations in December 2025, 7.4% below the same month last year.

    Same month last year: $131.1M; its normal month is $0.

    See the evidence
    This period
    $121.4M (December 2025)
    Normal month (median of 5 earlier)
    $0
    Typical spread (median absolute deviation)
    $204K
    How far from its usual level
    +121.4
    Same month last year
    $131.1M
    History used
    6,621 days
    2020-12-01: $758K2021-12-01: $02022-12-01: $02023-12-01: $02024-12-01: $131.1M2025-12-01: $121.4M
    December 20255 earlier monthsnormal: $0

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  4. 23 Dec 2025Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G26K0197 ($121.4M) (dated 17 Dec 2025)

  5. 1 Dec 2025Government contracts change

    booked $27.2M in federal contract and grant obligations in November 2025, 85× the same month last year.

    Same month last year: $319K; its normal month is $704K.

    See the evidence
    This period
    $27.2M (November 2025)
    Normal month (median of 5 earlier)
    $704K
    Typical spread (median absolute deviation)
    $166K
    How far from its usual level
    +26.5
    Same month last year
    $319K
    History used
    6,590 days
    2020-11-01: $02021-11-01: $772K2022-11-01: $871K2023-11-01: $704K2024-11-01: $319K2025-11-01: $27.2M
    November 20255 earlier monthsnormal: $704K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  6. 19 Nov 2025Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G26K0127 ($26.9M) (dated 13 Nov 2025)

  7. 27 Oct 2025Government contracts change

    booked $26.9M in federal contract and grant obligations in October 2025, 28× the same month last year.

    Same month last year: $968K; its normal month is $621K.

    See the evidence
    This period
    $26.9M (October 2025)
    Normal month (median of 5 earlier)
    $621K
    Typical spread (median absolute deviation)
    $128K
    How far from its usual level
    +26.2
    Same month last year
    $968K
    History used
    1,856 days
    2020-10-01: $493K2021-10-01: $524K2022-10-01: $820K2023-10-01: $621K2024-10-01: $968K2025-10-01: $26.9M
    October 20255 earlier monthsnormal: $621K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  8. 22 Oct 2025Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G26K0067 ($26.8M) (dated 16 Oct 2025)

  9. 23 Sep 2025Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G25K0664 ($26.8M) (dated 17 Sep 2025)

  10. 26 Aug 2025Government contracts change

    booked $26.2M in federal contract and grant obligations in August 2025, against none in the same month last year.

    See the evidence
    This period
    $26.2M (August 2025)
    Normal month (median of 5 earlier)
    $0
    Typical spread (median absolute deviation)
    $118K
    How far from its usual level
    +26.2
    Same month last year
    $0
    History used
    6,499 days
    2020-08-01: $02021-08-01: $168K2022-08-01: $02023-08-01: $118K2024-08-01: $02025-08-01: $26.2M
    August 20255 earlier monthsnormal: $0

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  11. 26 Aug 2025Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G25K0594 ($26.3M) (dated 20 Aug 2025)

  12. 3 Aug 2025Government contracts change

    booked $33.7M in federal contract and grant obligations in July 2025, against none in the same month last year.

    See the evidence
    This period
    $33.7M (July 2025)
    Normal month (median of 4 earlier)
    $2K
    Typical spread (median absolute deviation)
    $2K
    How far from its usual level
    +33.7
    Same month last year
    $0
    History used
    1,764 days
    2021-07-01: $4K2022-07-01: $48K2023-07-01: $02024-07-01: $02025-07-01: $33.7M
    July 20254 earlier monthsnormal: $2K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  13. 3 Aug 2025Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G25K0516 ($11.3M) (dated 28 Jul 2025)

  14. 3 Aug 2025Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G25K0515 ($22.4M) (dated 28 Jul 2025)

  15. 24 Jun 2025Government contracts change

    booked $303.6M in federal contract and grant obligations in June 2025, against none in the same month last year.

    See the evidence
    This period
    $303.6M (June 2025)
    Normal month (median of 5 earlier)
    $43K
    Typical spread (median absolute deviation)
    $70K
    How far from its usual level
    +303.6
    Same month last year
    $0
    History used
    6,437 days
    2020-06-01: $159K2021-06-01: $382K2022-06-01: $02023-06-01: $43K2024-06-01: $02025-06-01: $303.6M
    June 20255 earlier monthsnormal: $43K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  16. 17 Jun 2025Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G25K0421 ($24.6M) (dated 11 Jun 2025)

  17. 17 Jun 2025Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G25K0385 ($73.2M) (dated 11 Jun 2025)

  18. 17 Jun 2025Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G25K0288 ($205.9M) (dated 11 Jun 2025)

  19. 7 May 2025Lobbying record

    DAVITA, INC.: new lobbying registration (CONTINENTAL STRATEGY, LLC) (dated 28 Apr 2025)

  20. 21 Apr 2025Lobbying record

    DAVITA INC: lobbying engagement terminated (AVOQ, LLC) (dated 31 Jan 2025)

  21. 7 Apr 2025Lobbying record

    DAVITA, INC.: lobbying engagement terminated (HORIZON GOVERNMENT AFFAIRS) (dated 31 Mar 2025)

  22. 6 Apr 2025Government contracts change

    booked $12.1M in federal contract and grant obligations in March 2025, 20× the same month last year.

    Same month last year: $593K; its normal month is $933K.

    See the evidence
    This period
    $12.1M (March 2025)
    Normal month (median of 5 earlier)
    $933K
    Typical spread (median absolute deviation)
    $316K
    How far from its usual level
    +11.2
    Same month last year
    $593K
    History used
    6,346 days
    2020-03-01: $864K2021-03-01: $1.5M2022-03-01: $1.2M2023-03-01: $933K2024-03-01: $593K2025-03-01: $12.1M
    March 20255 earlier monthsnormal: $933K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  23. 2 Apr 2025Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G25K0256 ($10.6M) (dated 27 Mar 2025)

  24. 7 Feb 2025Lobbying record

    DAVITA, INC.: new lobbying registration (S-3 GROUP) (dated 1 Jan 2025)

  25. 21 Jan 2025Lobbying record

    DAVITA INC.: lobbying engagement terminated (WEST FRONT STRATEGIES LLC) (dated 31 Dec 2024)

  26. 9 Jan 2025Lobbying record

    DAVITA, INC: new lobbying registration (APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)) (dated 1 Sep 2024)

  27. 24 Dec 2024Government contracts change

    booked $131.1M in federal contract and grant obligations in December 2024, against a normal month of -$47K.

    Same month a year earlier: -$204K.

    See the evidence
    This period
    $131.1M (December 2024)
    Normal month (median of 5 earlier)
    -$47K
    Typical spread (median absolute deviation)
    $47K
    How far from its usual level
    +131.1
    Same month last year
    -$204K
    History used
    6,256 days
    2019-12-01: $02020-12-01: $758K2021-12-01: $02022-12-01: $02023-12-01: $02024-12-01: $131.1M
    December 20245 earlier monthsnormal: -$47K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  28. 23 Dec 2024Government contracts record

    DAVITA INC.: new Department of Veterans Affairs contract 36C10G25K0021 ($131.3M) (dated 17 Dec 2024)

  29. 13 Sep 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 13 Sep 2024Filings record

    Director or officer change

  31. 10 Apr 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 10 Apr 2024Filings record

    Director or officer change

  33. 10 Feb 2024Short interest and volume change

    had 5.0M shares sold short in the 31 Jan 2024 report, 1.8× the same report last year.

    Same report last year: 2.7M; its normal report is 3.0M.

    See the evidence
    This period
    5.0M (the 31 Jan 2024 report)
    Normal report (median of 24 earlier)
    3.0M
    Typical spread (median absolute deviation)
    348K
    How far from its usual level
    +3.9
    Same report last year
    2.7M
    History used
    2,224 days
    2023-01-31: 2.7M2023-02-15: 2.8M2023-02-28: 2.9M2023-03-15: 3.2M2023-03-31: 3.0M2023-04-14: 3.0M2023-04-28: 3.0M2023-05-15: 2.8M2023-05-31: 2.8M2023-06-15: 2.6M2023-06-30: 2.6M2023-07-14: 2.8M2023-07-31: 2.1M2023-08-15: 2.5M2023-08-31: 2.9M2023-09-15: 3.3M2023-09-29: 3.6M2023-10-13: 5.7M2023-10-31: 5.1M2023-11-15: 6.7M2023-11-30: 6.4M2023-12-15: 6.0M2023-12-29: 5.4M2024-01-12: 5.9M2024-01-31: 5.0M
    the 31 Jan 2024 report24 earlier reportsnormal: 3.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 25 Jan 2024Short interest and volume change

    had 5.9M shares sold short in the 12 Jan 2024 report, 2.1× the same report last year.

    Same report last year: 2.8M; its normal report is 3.0M.

    See the evidence
    This period
    5.9M (the 12 Jan 2024 report)
    Normal report (median of 24 earlier)
    3.0M
    Typical spread (median absolute deviation)
    297K
    How far from its usual level
    +6.6
    Same report last year
    2.8M
    History used
    2,205 days
    2023-01-13: 2.8M2023-01-31: 2.7M2023-02-15: 2.8M2023-02-28: 2.9M2023-03-15: 3.2M2023-03-31: 3.0M2023-04-14: 3.0M2023-04-28: 3.0M2023-05-15: 2.8M2023-05-31: 2.8M2023-06-15: 2.6M2023-06-30: 2.6M2023-07-14: 2.8M2023-07-31: 2.1M2023-08-15: 2.5M2023-08-31: 2.9M2023-09-15: 3.3M2023-09-29: 3.6M2023-10-13: 5.7M2023-10-31: 5.1M2023-11-15: 6.7M2023-11-30: 6.4M2023-12-15: 6.0M2023-12-29: 5.4M2024-01-12: 5.9M
    the 12 Jan 2024 report24 earlier reportsnormal: 3.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 19 Jan 2024Lobbying record

    DAVITA, INC.: lobbying engagement terminated (AKIN GUMP STRAUSS HAUER & FELD) (dated 31 Dec 2023)

  36. 11 Jan 2024Short interest and volume change

    had 5.4M shares sold short in the 29 Dec 2023 report, 2.1× the same report last year.

    Same report last year: 2.6M; its normal report is 2.9M.

    See the evidence
    This period
    5.4M (the 29 Dec 2023 report)
    Normal report (median of 24 earlier)
    2.9M
    Typical spread (median absolute deviation)
    276K
    How far from its usual level
    +6.1
    Same report last year
    2.6M
    History used
    2,191 days
    2022-12-30: 2.6M2023-01-13: 2.8M2023-01-31: 2.7M2023-02-15: 2.8M2023-02-28: 2.9M2023-03-15: 3.2M2023-03-31: 3.0M2023-04-14: 3.0M2023-04-28: 3.0M2023-05-15: 2.8M2023-05-31: 2.8M2023-06-15: 2.6M2023-06-30: 2.6M2023-07-14: 2.8M2023-07-31: 2.1M2023-08-15: 2.5M2023-08-31: 2.9M2023-09-15: 3.3M2023-09-29: 3.6M2023-10-13: 5.7M2023-10-31: 5.1M2023-11-15: 6.7M2023-11-30: 6.4M2023-12-15: 6.0M2023-12-29: 5.4M
    the 29 Dec 2023 report24 earlier reportsnormal: 2.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  37. 28 Dec 2023Short interest and volume change

    had 6.0M shares sold short in the 15 Dec 2023 report, 2.2× the same report last year.

    Same report last year: 2.7M; its normal report is 2.9M.

    See the evidence
    This period
    6.0M (the 15 Dec 2023 report)
    Normal report (median of 24 earlier)
    2.9M
    Typical spread (median absolute deviation)
    195K
    How far from its usual level
    +10.7
    Same report last year
    2.7M
    History used
    2,177 days
    2022-12-15: 2.7M2022-12-30: 2.6M2023-01-13: 2.8M2023-01-31: 2.7M2023-02-15: 2.8M2023-02-28: 2.9M2023-03-15: 3.2M2023-03-31: 3.0M2023-04-14: 3.0M2023-04-28: 3.0M2023-05-15: 2.8M2023-05-31: 2.8M2023-06-15: 2.6M2023-06-30: 2.6M2023-07-14: 2.8M2023-07-31: 2.1M2023-08-15: 2.5M2023-08-31: 2.9M2023-09-15: 3.3M2023-09-29: 3.6M2023-10-13: 5.7M2023-10-31: 5.1M2023-11-15: 6.7M2023-11-30: 6.4M2023-12-15: 6.0M
    the 15 Dec 2023 report24 earlier reportsnormal: 2.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  38. 12 Dec 2023Short interest and volume change

    had 6.4M shares sold short in the 30 Nov 2023 report, 2.1× the same report last year.

    Same report last year: 3.1M; its normal report is 2.9M.

    See the evidence
    This period
    6.4M (the 30 Nov 2023 report)
    Normal report (median of 24 earlier)
    2.9M
    Typical spread (median absolute deviation)
    182K
    How far from its usual level
    +12.3
    Same report last year
    3.1M
    History used
    2,162 days
    2022-11-30: 3.1M2022-12-15: 2.7M2022-12-30: 2.6M2023-01-13: 2.8M2023-01-31: 2.7M2023-02-15: 2.8M2023-02-28: 2.9M2023-03-15: 3.2M2023-03-31: 3.0M2023-04-14: 3.0M2023-04-28: 3.0M2023-05-15: 2.8M2023-05-31: 2.8M2023-06-15: 2.6M2023-06-30: 2.6M2023-07-14: 2.8M2023-07-31: 2.1M2023-08-15: 2.5M2023-08-31: 2.9M2023-09-15: 3.3M2023-09-29: 3.6M2023-10-13: 5.7M2023-10-31: 5.1M2023-11-15: 6.7M2023-11-30: 6.4M
    the 30 Nov 2023 report24 earlier reportsnormal: 2.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  39. 28 Nov 2023Short interest and volume change

    had 6.7M shares sold short in the 15 Nov 2023 report, 2.2× the same report last year.

    Same report last year: 3.1M; its normal report is 2.9M.

    See the evidence
    This period
    6.7M (the 15 Nov 2023 report)
    Normal report (median of 24 earlier)
    2.9M
    Typical spread (median absolute deviation)
    182K
    How far from its usual level
    +13.5
    Same report last year
    3.1M
    History used
    2,147 days
    2022-11-15: 3.1M2022-11-30: 3.1M2022-12-15: 2.7M2022-12-30: 2.6M2023-01-13: 2.8M2023-01-31: 2.7M2023-02-15: 2.8M2023-02-28: 2.9M2023-03-15: 3.2M2023-03-31: 3.0M2023-04-14: 3.0M2023-04-28: 3.0M2023-05-15: 2.8M2023-05-31: 2.8M2023-06-15: 2.6M2023-06-30: 2.6M2023-07-14: 2.8M2023-07-31: 2.1M2023-08-15: 2.5M2023-08-31: 2.9M2023-09-15: 3.3M2023-09-29: 3.6M2023-10-13: 5.7M2023-10-31: 5.1M2023-11-15: 6.7M
    the 15 Nov 2023 report24 earlier reportsnormal: 2.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  40. 10 Nov 2023Short interest and volume change

    had 5.1M shares sold short in the 31 Oct 2023 report, 1.4× the same report last year.

    Same report last year: 3.6M; its normal report is 2.9M.

    See the evidence
    This period
    5.1M (the 31 Oct 2023 report)
    Normal report (median of 24 earlier)
    2.9M
    Typical spread (median absolute deviation)
    182K
    How far from its usual level
    +8.0
    Same report last year
    3.6M
    History used
    2,132 days
    2022-10-31: 3.6M2022-11-15: 3.1M2022-11-30: 3.1M2022-12-15: 2.7M2022-12-30: 2.6M2023-01-13: 2.8M2023-01-31: 2.7M2023-02-15: 2.8M2023-02-28: 2.9M2023-03-15: 3.2M2023-03-31: 3.0M2023-04-14: 3.0M2023-04-28: 3.0M2023-05-15: 2.8M2023-05-31: 2.8M2023-06-15: 2.6M2023-06-30: 2.6M2023-07-14: 2.8M2023-07-31: 2.1M2023-08-15: 2.5M2023-08-31: 2.9M2023-09-15: 3.3M2023-09-29: 3.6M2023-10-13: 5.7M2023-10-31: 5.1M
    the 31 Oct 2023 report24 earlier reportsnormal: 2.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

Showing the newest 40 of 161 entries; narrow the window or the kind of data to see older ones.

Not listed: 240 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000927066
Ticker
DVA
Domain
davita.com
Employer name
DaVita, Inc. (1 unverified)
Hq location
CO|DENVER|80202 (1 unverified)
Lobbying client
davita, davita healthcare partners, jefferson business consulting on behalf of davita
Name
Aberdeen Dialysis, LLC, Adair Dialysis, LLC, Afton Dialysis, LLC, Ahern Dialysis, LLC and 731 more
Uei
PCJQZRE36Z73
Wikidata
Q5207184
Wikipedia
DaVita
  • DOL H-1B labor condition applications and PERM certifications1354 data points7 Oct 2019 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)57 records, 243 data points30 Dec 1899 to 30 Sep 2026
  • SEC Form 13F institutional holdings2 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)166 records11 Feb 2016 to 29 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1085 data points31 Dec 2006 to 27 Oct 2026
  • SEC Form 4 insider transactions108 records, 340 data points18 Feb 2016 to 29 Oct 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards37 records, 1063 data points15 Nov 2007 to 3 Nov 2026
  • Wikipedia pageviews2881 data points1 Jan 2019 to 21 Nov 2026